19 June 2013
Keywords: analysts, raise, npvs, promacta, rezonic, tykerb, still
Article | 02 July 2007
At a recent meeting held in London, UK drug major GlaxoSmithKline updated analysts on the latest developments in its oncology ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 July 2007
9 July 2007
© 2013 thepharmaletter.com